高钙血症在晚期前列腺腺癌患者中的意义尚不明确。

Federal practitioner : for the health care professionals of the VA, DoD, and PHS Pub Date : 2020-07-01 DOI:10.12788/fp.0018

G. Alhatemi, Rafal Alhatemi, H. Aldiwani, Marwah Hussein, E. Levi, P. Jasti

{"title":"高钙血症在晚期前列腺腺癌患者中的意义尚不明确。","authors":"G. Alhatemi, Rafal Alhatemi, H. Aldiwani, Marwah Hussein, E. Levi, P. Jasti","doi":"10.12788/fp.0018","DOIUrl":null,"url":null,"abstract":"Hypercalcemia in the setting of prostate cancer is rare with an uncertain pathophysiology and more research is needed into the role of parathyroid hormone-related peptide as a growth factor and possibly target-directed monoclonal antibody therapies.","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Hypercalcemia Is of Uncertain Significance in Patients With Advanced Adenocarcinoma of the Prostate.\",\"authors\":\"G. Alhatemi, Rafal Alhatemi, H. Aldiwani, Marwah Hussein, E. Levi, P. Jasti\",\"doi\":\"10.12788/fp.0018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hypercalcemia in the setting of prostate cancer is rare with an uncertain pathophysiology and more research is needed into the role of parathyroid hormone-related peptide as a growth factor and possibly target-directed monoclonal antibody therapies.\",\"PeriodicalId\":94009,\"journal\":{\"name\":\"Federal practitioner : for the health care professionals of the VA, DoD, and PHS\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Federal practitioner : for the health care professionals of the VA, DoD, and PHS\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.12788/fp.0018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.12788/fp.0018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

前列腺癌症中的高钙血症是罕见的，病理生理学不确定，需要对甲状旁腺激素相关肽作为生长因子的作用进行更多的研究，并可能进行靶向单克隆抗体治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Hypercalcemia Is of Uncertain Significance in Patients With Advanced Adenocarcinoma of the Prostate.

Hypercalcemia in the setting of prostate cancer is rare with an uncertain pathophysiology and more research is needed into the role of parathyroid hormone-related peptide as a growth factor and possibly target-directed monoclonal antibody therapies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Federal practitioner : for the health care professionals of the VA, DoD, and PHS

自引率

0.00%

发文量